Venture Capital

cell therapy oncology cancer CAR-T cells

Cellares, Ori dominate automated cell therapy production: report

The bulk of the field’s raised capital (81%) is held by Cellares and Ori Biotech, Tracxn said in a new report.

Fraiser Kansteiner Jun 18, 2026 10:10am

graphic image of China flags overlapping with US flags

Fierce Biotech

Will COINS Act kill China biotech licensing boom?

May 26, 2026 3:50pm

2026 year ahead look ahead preview forecast new year

3 biopharma CEOs explain why they are 'authentically optimistic'

Jan 6, 2026 11:54am

Massachusetts Massachusetts flag MA MA flag

Massachusetts shed R&D, manufacturing workers in '24: report

Aug 27, 2025 9:34am

newspaper

Sanofi, Trump, VC capital crunch—Fierce Pharma Asia

Aug 8, 2025 9:32am

orange pills and black inhaler

Avalyn adds $100M to advance inhaled versions of IPF pills

Jul 22, 2025 10:44am